WindMIL Therapeutics is a clinical stage oncology cell therapy company. We are leveraging our proprietary platform to develop a novel class of cell therapies called MILsâ„¢ (Marrow Infiltrating Lymphocytes) derived from memory T cells found in the bone marrow.